Table 1. Patients’ baseline demographics.
Characteristic | Budesonide/formoterol | All patients (n = 4,581) | ||
---|---|---|---|---|
80/4.5 µg b.i.d. (n = 119) | 160/4.5 µg b.i.d. (n = 3,106) | 2 × 160/4.5 µg b.i.d. (n = 1,355) | ||
Sex, no. (%) | ||||
Male | 42 (35) | 1,099 (35) | 490 (36) | 1,631 (36) |
Female | 77 (65) | 2,007 (65) | 865 (64) | 2,950 (64)a |
Age, years | ||||
Mean | 46.0 | 47.8 | 50.1 | 48.4 |
Range | 17 – 86 | 18 – 89 | 18 – 88 | 17 – 89 |
b.i.d. = twice daily. aIncludes 1 patient wrongly prescribed 320/18 µg who was only included in the “all patients” group.